Working… Menu

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis (M22)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01803867
Recruitment Status : Completed
First Posted : March 4, 2013
Last Update Posted : February 27, 2015
PRA Health Sciences
Information provided by (Responsible Party):
Acorda Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2014
Actual Study Completion Date : January 2015